Los Angeles's major cancer centres including Cedars-Sinai and City of Hope manage substantial numbers of Chronic Myeloid Leukaemia (CML) patients on long-term Imatinib therapy. Imatib 400mg, the Indian generic of Gleevec, provides identical treatment at significantly reduced cost.
Imatib targets the BCR-ABL protein created by the Philadelphia chromosome, transforming what was once a fatal leukaemia into a manageable chronic condition for most patients. It's also widely used for Gastrointestinal Stromal Tumours (GIST), targeting mutated KIT and PDGFRA receptors.
Generic Imatib from USFDA-inspected manufacturers offers the same efficacy as brand Gleevec at a fraction of the cost.
|
FAQ: How will I know if Imatib is working for my CML? Your oncologist will
monitor response through regular blood tests and specialized molecular tests
measuring BCR-ABL transcript levels, typically every 3 months initially. A
good response shows steadily declining BCR-ABL levels, ideally reaching
complete molecular remission where the abnormal genetic marker becomes
undetectable. |
